Booster dose of SARS-CoV-2 vaccine benefits lupus patients

By | July 13, 2022
People with systemic lupus erythematosus, or SLE, who received a “booster” dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent “breakthrough” COVID-19 infection, a new study shows.